• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION MAGNESIUM; PHOTOMETRIC METHOD, MAGNESIUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION MAGNESIUM; PHOTOMETRIC METHOD, MAGNESIUM Back to Search Results
Catalog Number 03P68-34
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/22/2024
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Section a1 - patient identifier complete entry = sample id (b)(6).All available patient information was included.Additional patient details are not available.
 
Event Description
The customer observed falsely elevated magnesium results for several patients on an architect c8000 analyzer.The following data was provided (customer¿s reference range is 1.6-2.6 mg/dl): sample id (b)(6); initial result was 6.8, repeat result was 1.9 mg/dl.Sample id (b)(6); initial result was 6.7, repeat result was 1.8 mg/dl.Sample id (b)(6); initial result was 7.2, repeat result was 2.5 mg/dl.Sample id (b)(6); initial result was 6.8, repeat result was 2.0 mg/dl.Sample id (b)(6); initial result was 6.7, repeat result was 1.9 mg/dl.Sample id (b)(6); initial result was 6.9, repeat result was 2.2 mg/dl.There was no impact to patient management reported.
 
Event Description
The customer observed falsely elevated magnesium results for several patients on an architect c8000 analyzer.The following data was provided (customer¿s reference range is 1.6-2.6 mg/dl): sample id (b)(6) initial result was 6.8, repeat result was 1.9 mg/dl.Sample id (b)(6) initial result was 6.7, repeat result was 1.8 mg/dl.Sample id (b)(6) initial result was 7.2, repeat result was 2.5 mg/dl.Sample id (b)(6) initial result was 6.8, repeat result was 2.0 mg/dl.Sample id (b)(6) initial result was 6.7, repeat result was 1.9 mg/dl.Sample id (b)(6) initial result was 6.9, repeat result was 2.2 mg/dl.There was no impact to patient management reported.
 
Manufacturer Narrative
The complaint investigation for a falsely elevated magnesium result on an architect c8000 analyzer included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, and device history record review.Trending review determined no related trend for the issue for the product.As part of the troubleshooting, all samples were repeated on another analyzer with same reagent lot and generated lower normal results.The technician discarded the questionable reagent kit and has not had any further discrepant results.The quality control results were high prior to the discrepant results being generated; however, the reagent was recalibrated, and quality control results were then performing within the expected ranges, which shows that the assay was performing as expected.Additionally, the field service engineer found the 1ml syringe on the wash solution pump was installed incorrectly.The fse replaced both 1ml syringes, check valves, cuvette dry tip due to discoloration, and performed light path alignment, cuvette washer alignment, mixer alignment, sample/r1/r2 pipettor calibrations, and flushed fluids and performed cuvette washer test.After that, the instrument returned to normal function.No additional issues were identified.Return testing was not completed as returns were not available.Device history record review did not identify any non-conformances or deviations with the likely cause lot and complaint issue.Manufacturing documentation for the likely cause lot was reviewed and did not identify any issues.Labeling was reviewed and sufficiently addresses the customer's issue.Based on the information provided and abbott diagnostics¿ complaint investigation, no systemic issue or deficiency of the magnesium reagent, lot number 54910ud00, was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MAGNESIUM
Type of Device
PHOTOMETRIC METHOD, MAGNESIUM
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key19073341
MDR Text Key340596470
Report Number3005094123-2024-00179
Device Sequence Number1
Product Code JGJ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/04/2024
Device Catalogue Number03P68-34
Device Lot Number54910UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/22/2024
Initial Date FDA Received04/09/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/29/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/02/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC C8 PROC MOD, 01G06-11, (B)(6) ; ARC C8 PROC MOD, 01G06-11, (B)(6)
-
-